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Abstract The nuclear Dbf2-related (NDR) family of protein
serine/threonine kinases comprises mammalian NDR and large
tumor suppressor (LATS) kinases, their orthologs from Droso-
phila melanogaster and Caenorhabditis elegans, and a number
of related kinases from yeast and plants. The members of this
family were independently implicated in various aspects of the
control of cell division and morphogenesis. They are crucial
regulators of the actin and tubulin cytoskeletal organization
during polarized growth and cytokinesis in yeast. Furthermore,
they are key players in control of proliferation and morphology
of many cell types in D. melanogaster and C. elegans. In mam-
malians, the LATS kinase is a tumor suppressor, negatively
regulating the cyclin-dependent kinase CDK1, cell proliferation
rate, and modulating cell survival.
+ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The NDR (nuclear Dbf2-related) family of protein serine/
threonine kinases (Fig. 1) is a conserved subclass of the AGC
(protein kinases A, G, and C) group of kinases, and it in-
cludes mammalian protein kinases NDR1 and NDR2, Droso-
phila melanogaster TRC, Caenorhabditis elegans SAX-1, mam-
malian D. melanogaster, and C. elegans large tumor
suppressor (LATS) kinases, Neurospora crassa Cot-1, Ustilago
maydis UKC1, Saccharomyces cerevisiae Cbk1, Dbf2 and
Dbf20, Schizosaccharomyces pombe Orb6 and Sid2, and a
number of plant kinases [1]. The members of the NDR family
are more distantly related to other conserved protein kinases
such as the Ghenghis Khan (GEK) kinases DMPK and
MRCK, the ROCK kinase, and the budding yeast kinase
Rim15 (sometimes considered also as a NDR family member).
Regarding their kinase domain sequence, NDR family ki-
nases are related to the other members of the AGC group
kinases, e.g. PKA, PKB, PKG, PKCs, PRK, p70S6K ,
p90RSK , and PDK1. They contain all 12 subdomains of the
kinase catalytic domain as described by Hanks and Hunter
[2]. However, a unique feature of NDR family kinases is an
insert of about 30^60 amino acids located between subdo-
mains VII and VIII. The function of this insert is not well
understood, but in the case of NDR1, it accommodates a non-
consensus nuclear localization signal [3]. In addition, all mem-
bers of the NDR family have a conserved but poorly charac-
terized N-terminal regulatory domain of di¡erent length. In
NDR, this domain consists of 87 amino acids, and it encom-
passes a region which is predicted to form an amphiphilic
K-helix responsible for binding the calcium sensor protein
S100B [4]. Finally, the C-terminal extension contains a broadly
conserved hydrophobic phosphorylation motif that is an im-
portant regulatory element within the AGC group of protein
kinases [5].
Apart from their high sequence homology, the function of
the NDR family kinases (Table 1) has been conserved over
long evolutionary distances, mainly involving various aspects
of cell division and morphogenesis. In this article, we review
the modes of regulation of NDR family kinases, and summa-
rize the current knowledge about physiological functions of
these kinases in di¡erent organisms.
2. Regulation of NDR protein kinase family
The molecular mechanisms of regulation of protein kinases
from the NDR family are best studied for the human NDR1
isoform which is presumed to serve, due to the high homology
in the catalytic and regulatory domains among family mem-
bers, as the prototype for the regulation of this kinase family.
Although the physiological upstream signal for NDR activa-
tion was not yet identi¢ed, NDR is potently activated in vivo
by treatment with the protein phosphatase 2A inhibitor oka-
daic acid, indicating involvement of phosphorylation at serine/
threonine residues in the regulation of NDR activity. Indeed,
we demonstrated that activation of NDR1 involves phosphor-
ylation of two regulatory residues, Ser-281 from the activation
segment, which is located immediately next to the kinase do-
main insert, and Thr-444 from the hydrophobic motif located
in the C-terminal region (Fig. 2 and [6]). The importance of
these residues is not surprising, because similar observations
were also made for numerous other AGC group kinases (re-
viewed in [7]). The regulatory potential of phosphorylation of
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the budding yeast NDR homologue Dbf2 at two equivalent
residues Ser-374 and Thr-544 supports this mechanism [8].
Based upon structural analysis of the prototypical AGC ki-
nase PKA, the activation segment residue is found in its phos-
phorylated form to align the catalytic site of this enzyme,
thereby generating an active kinase conformation [9]. The
recently resolved structure of PKBL con¢rmed the crucial
role of the activation segment residue, and de¢ned the func-
tion of the hydrophobic motif site which, upon phosphoryla-
tion, undergoes a series of interactions with KB- and KC-heli-
ces of the catalytic domain, thereby promoting disorder to
order transition of this part of molecule with concomitant
restructuring of the activation segment and recon¢guration
of the kinase bilobal structure [5,10].
In our recent work, we found that the Ser-281 site is an
autophosphorylation residue in vivo because kinase-inactive
NDR1 mutant does not become phosphorylated at this posi-
tion. Hence, the kinase activity of NDR1 is required for the
phosphorylation on Ser-281 in the activation segment [11]. In
most other AGC kinases including PKB, p70S6K , SGK,
p90RSK , and PKC isoforms, however, the activation segment
residue has been reported to be a target of phosphoinositide-
dependent kinase PDK1 (reviewed in [12]). The pivotal role of
PDK1 in phosphorylation of AGC kinases is supported by the
high conservation of activation segment residues within the
AGC family and by the fact that a number of AGC kinases
can directly interact with PDK1. However, more recent stud-
ies employing PDK13=3 ES cells con¢rmed that there exist
several exceptions to this general concept. Some AGC kinases
such as PKA, PKCN, AMPK, MSK1, and PRK2 become
e⁄ciently phosphorylated at their activation segment residues
in absence of PDK1 [13,14], and at least two of these kinases
undergo autophosphorylation [15,16]. Our earlier observa-
tions on NDR1 demonstrated that this kinase is also not
modi¢ed by PDK1, neither in vivo nor in vitro [6]. This can
be explained by the fact that the NDR1 sequence surrround-
ing Ser-281 (see Fig. 2) displays obvious variations in P+1 and
+2 positions to the highly conserved PDK1 consensus target
site (Ser/Thr-Phe-Cys-Gly-Thr-Xaa-Asp/Glu-Tyr-Xaa-Ala-
Pro-Glu, where Ser/Thr is the phosphoacceptor site and Xaa
stands for a hydrophobic residue). Thus, in contrast to most
AGC group kinases, NDR is not targeted by PDK1, but in-
stead it becomes e⁄ciently autophosphorylated at the activa-
tion segment residue both in vivo and in vitro.
In contrast to the activation segment residue, the hydro-
phobic motif site Thr-444 is targeted by an as yet unidenti¢ed
upstream kinase, because the kinase-inactive NDR1, as well
as the Ser-281 alanine mutant, become phosphorylated at
Thr-444 virtually to the same extent as wild-type NDR1 in
vivo [11]. Signi¢cantly, Thr-444 is £anked by hydrophobic
amino acids which are in this region conserved among almost
all AGC group kinases (consensus Phe-Xaa-Xaa-Phe-Ser/Thr-
Phe/Tyr; except NDR1 has a tyrosine instead of phenylala-
nine at the P31; see Fig. 2). There is an ongoing dispute
concerning the mechanism of action and identity of upstream
kinases phosphorylating the hydrophobic motif residues in
AGC protein kinases. For the NDR kinase family, there are
some signi¢cant clues suggesting that the upstream kinases are
members of the Ste20 family. First, the upstream kinase of
Dbf2 was identi¢ed as Cdc15, one of the budding yeast Ste20-
Fig. 1. NDR family of protein kinases. The NDR family of protein serine/threonine kinases is a subclass of AGC kinase group. Its members
are highly conserved in evolutionary distant species and are implicated in various aspects of cell morphogenesis and growth control. The phylo-
genetic tree illustrates the relationship among the full-length protein sequences of the di¡erent NDR family members from Homo sapiens (hs),
D. melanogaster (dm), C. elegans (ce), U. maydis (um), N. crassa (nc), S. cerevisiae (sc), and S. pombe (sp) (constructed using GrowTree se-
quence analysis program from Wisconsin Package software). Schematic diagrams of the NDR family kinases depict the kinase catalytic do-
mains (red), kinase domain inserts (blue), and the N- and C-terminal extensions (green). On the right, the percentage of sequence identity and
similarity between the kinase catalytic domains of NDR family members and the catalytic domain of human NDR1 is indicated.
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like kinases [8]. Second, the ¢ssion yeast Ste20-like kinase
Pak1/Shk1 was reported to genetically interact with NDR
homologue Orb6 [17]. Third, two other Ste20 family kinases,
Cdc7 and Sid1, were placed upstream of the second ¢ssion
yeast NDR homologue Sid2 [18].
Apart from the phosphorylation-mediated control of NDR
kinase activity, NDR family kinases appear to be regulated
also through their conserved, N-terminally extended regula-
tory domains. In NDR1, this domain consists of 87 amino
acids and it encompasses a region which is predicted to form
an amphiphilic K-helix responsible for the binding to S100B,
an EF-hand Ca2þ-binding protein of S100 family [4]. We
found that Ca2þ/S100B promotes, in a Ca2þ- and concentra-
tion-dependent manner, both autophoshorylation of NDR
and its transphosphorylation activity towards an exogenous
peptide substrate. Furthermore, Ca2þ/S100B increases NDR1
phosphorylation on the two regulatory sites Ser-281 and Thr-
444 [11]. Recently, a class of broadly conserved proteins called
Mob (from Mps one binder [19]), which display no signi¢cant
homology to other known polypeptides, was identi¢ed to bind
and activate several members of the NDR family (see Section
3). Our unpublished observations suggest that these proteins
might bind to NDR kinase also through the N-terminal reg-
ulatory domain, in a manner similar to the binding of S100B.
Therefore, we term this NDR regulatory region the SMA
(S100B and Mob1 association) domain. In the classical cal-
modulin (CaM)-dependent kinases (and also in the twitchin
kinase), the autoinhibitory CaM/S100-binding domain is lo-
cated directly C-terminal to the kinase catalytic domain, and
sterically hinders the access of substrates to the active site of
kinase [20]. This inhibition is relieved upon binding of CaM
or S100 proteins. The mode of action of the SMA domain,
however, seems to be di¡erent. It is located N-terminal to the
kinase domain, and it does not appear to be autoinhibitory
since its deletion results in a kinase with signi¢cantly attenu-
ated activity [4]. Thus, S100B and Mob1 might activate NDR
family kinases by inducing a positive allosteric conformational
change rather than by relieving an autoinhibited conforma-
tion. None the less, since mutations in the SMA domain a¡ect
the phosphorylation at the hydrophobic motif residue, it is
also conceivable that SMA-interacting proteins, such as
S100B or Mob1, mediate the targeting of an activating up-
stream kinase to NDR [11]. This idea is supported by the
¢nding that Mob1 is essential for the phosphorylation of
Dbf2 by its upstream kinase Ccd15 [8]. Signi¢cantly, we
have recently found NDR1 autophosphorylation at the resi-
due Thr-74 from the SMA domain. This residue proved to be
crucial for the NDR1 activity in vivo; however, in contrast to
Ser-281 and Thr-444, it seems to be involved solely in binding
to S100B rather than regulating the activity of NDR1 per se.
Of note, phosphorylatable residues serine or threonine are
well conserved at this position in most NDR family kinases
(except Dbf2 and 20, Sid2, and Cot-1 where the neighboring
glutamates may, in part, substitute the negative charge of the
phosphate moiety, see Fig. 2).
The functional interaction of NDR1 with Ca2þ/S100B in-
dicated that Ca2þ levels may be an important factor in the
regulation of NDR activity in vivo. In the presence of S100B,
NDR1 becomes sensitive to changes in Ca2þ concentration in
the 1^100 WM range, which corresponds well to the Ca2þ
concentrations achieved in vivo and to the a⁄nity of Ca2þ
sensor S100B for these ions [4]. In fact, we found that the cell
permeable Ca2þ-chelating agent 1,2-bis(o-aminophenoxy)-
ethane-N,N,NP,NP-tetraacetic acid tetra(acetoxymethyl)ester
Fig. 2. Structure of NDR. The domain structure of NDR1 is shown including (i) the N-terminal regulatory SMA domain containing the
S100B- and Mob1-binding region with the autophosphorylation residue Thr-74, (ii) the catalytic domain spliced by a 33 amino acid insert (en-
compassing a non-consensus NLS sequence) and containing the activation segment residue Ser-281, (iii) the C-terminal extension comprising
the regulatory hydrophobic motif with the residue Thr-444. Below, conservation of the S100B-binding region, activation segment, and the hy-
drophobic motif among the members of NDR family is shown. The identical residues are boxed in black and similar residues are in gray. The
phosphorylation sites are typed in bold.
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(BAPTA-AM) suppresses the activity and phosphorylation of
NDR1 on both Ser-281 and Thr-444, and speci¢cally, these
e¡ects can be reversed upon addition of the sarcoplasmatic-
endoplasmatic reticulum Ca2þ ATPase (SERCA) Ca2þ pump
inhibitor thapsigargin [11]. However, since the treatment of
cells with Ca2þ-ionophore A23187 or thapsigargin results
only in a partial activation of NDR1, it seems likely that
Ca2þ is necessary, but not su⁄cient, for the activity of
NDR; i.e. an additional signal may be needed to achieve
full NDR activation. Nevertheless, a novel, Ca2þ-dependent
mechanism of NDR regulation can be predicted, involving the
S100B-mediated stimulation of autophosphorylation on Ser-
281 and the phosphorylation of Thr-444 by an as yet uniden-
ti¢ed Ca2þ-dependent upstream kinase (Fig. 3).
A further level of NDR kinase family regulation has been
discovered only very recently. Mutants in genes encoding a
novel family of giant proteins of 300 kDa from yeast and
Drosophila, Pag1, Mor2, and FRY, give rise to phenotypes
that are indistinguishable from mutants in the corresponding
NDR family kinases Cbk1, Orb6, and TRC, respectively [21^
23]. They interact genetically, and at least for Cbk1 and Pag1,
they also undergo a physical interaction. The similarity among
the family members from di¡erent species is found in ¢ve
mostly large domains separated by short regions of little or
no similarity. Despite their length, the primary sequence of
these proteins does not give any information about their func-
tion. Nevertheless, it seems likely that they may function as
sca¡olds recruiting other regulatory proteins and/or down-
stream targets, thereby organizing NDR signaling complexes
in the di¡erent species.
3. In vivo function of NDR protein kinase family
3.1. S. cerevisiae and S. pombe
Cell growth and morphogenesis are complex processes that
are tightly linked to the cell cycle and division. Substantial
progress has been achieved in understanding how these intri-
cate processes are coordinated in lower eukaryotes, in partic-
ular in the budding yeast S. cerevisiae and the ¢ssion yeast
S. pombe. Numerous genetic, cytological and biochemical
studies con¢rmed that the protein kinases of the NDR family
Fig. 3. Model of NDR regulation. NDR1 becomes autophosphory-
lated on the three indicated residues, Thr-74, Ser-281, and Thr-444,
in vitro. The autophosphorylation and the kinase activity of NDR1
are promoted by an interaction with Ca2þ/S100B. The Ser-281 site
is autophosphorylated also in vivo. In contrast, Thr-444 is targeted
mainly by an as yet unidenti¢ed upstream kinase. Nevertheless,
both phosphorylation events are Ca2þ-dependent and essential for
the NDR1 activity in vivo. Thr-74 residue is crucial for the binding
of S100B and Mob1, but it is not yet clear how its autophosphory-
lation in£uences the NDR1 activity in vivo. The mechanism of
NDR activation through Mob1 and a possible interplay between
S100B and Mob1 also remain to be elucidated.
Table 1
Function of NDR family protein kinases
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including S. cerevisiae Cbk1, Dbf2, and Dbf20 and S. pombe
Orb6 and Sid2 are, along with their interacting proteins, key
molecules orchestrating various aspects of cell morphogenesis
and cytokinesis such as maintenance of cell shape and cell
polarity, organization of actin and tubulin cytoskeleton, as
well as the concerted completion of mitotic exit, septum for-
mation, and daughter cell separation.
Inactivation of Cbk1, which is the closest NDR homologue
in S. cerevisiae, results in a phenotype characterized by large
aggregates of unseparated cells, round rather than ellipsoidal
cells, diminished apical growth, and a random instead of bi-
polar budding pattern [24,25]. Cbk1 localizes to sites of po-
larized growth and cell wall remodeling, such as the actively
expanding cell cortex during bud and mating projection for-
mation, and later, moves to the bud neck and daughter cell
nucleus during mitotic exit. This localization was shown to be
dependent on two Cbk1-associating partners, Hym1 and
Mob2 [25,26]. Mob2 is also required for Cbk1 kinase activity
that changes during the cell cycle, peaking late in M phase
and during the pheromone-induced G1 arrest. Interestingly,
although F-actin organization is essentially normal in cbk1v
and mob2v cells during vegetative growth, the exposure of
these cells to mating pheromone (K factor) led to profound
defects in formation of actin patches that concentrate at the
tips of growing mating projections in wild-type cells, but are
distributed evenly throughout the cell surface in pheromone-
treated mutant cells. This suggests that the role of Cbk1 and
Mob2 is the maintenance of persistent polarized growth in
such structures. Furthermore, Cbk1 apparently regulates a
broad range of genes encoding proteins with cell wall modi¢-
cation activities, such as scw11 and cts1 encoding glucanase
and chitinase, respectively. Activity of these proteins is essen-
tial for e⁄cient separation of mother and daughter cells after
cytokinesis. At least the expression of Cts1, and perhaps also
Scw1, is known to be controlled by Ace2, a daughter-speci¢c
transcription factor whose activity and proper localization to
the nuclei of daughter cells were shown to depend on Cbk1
and Mob2 [27]. Collectively, the results suggest that Cbk1
regulates two distinct cell morphogenesis pathways: an
Ace2-independent pathway that is required for polarized api-
cal growth and mating projection formation and an Ace2-de-
pendent pathway that is required for e⁄cient cell separation
following cytokinesis. It is also conceivable that Cbk1, togeth-
er with Mob2, form a part of the ‘cytokinesis checkpoint’
which ensures that the cell wall degradation does not com-
mence until membrane ¢ssion is completed.
Another NDR relative in budding yeast is the protein ki-
nase Dbf2 and its close homologue Dbf20. Cells carrying
temperature-sensitive alleles of dbf2 arrest at restrictive tem-
perature at the end of anaphase, with uniform large budded
‘dumbbell’ morphology, and display elongated mitotic spin-
dles indicative of incomplete nuclear division [28]. The kinase
activity of Dbf2 £uctuates during the cell cycle with maximum
in anaphase, which coincides with the localization of Dbf2 to
spindle pole bodies (SPBs or yeast centrosomes) [29,30]. Later
in mitosis, immediately prior to actin medial ring assembly,
Dbf2 migrates to the bud neck, consistent with its role in
cytokinesis. Dbf2 associates and colocalizes with Mob1, a
close homologue of Cbk1-interacting Mob2, and mRNAs
for both Dbf2 and Mob1 are periodically expressed during
the cell cycle peaking in mitosis. These two proteins constitute
an integral part of mitotic exit network (MEN) that governs
inactivation of mitotic cyclin-dependent kinases (CDKs) and
cytokinesis (reviewed in [31]). MEN is a signaling complex
that consists of the GTPase Tem1 with its two regulatory
proteins, a two-component GTPase-activating protein (GAP)
Bub2-Bfa1 and a guanine nucleotide-exchange factor (GEF)
Lte1, polo-like kinase Cdc5, Dbf2 upstream kinase Cdc15 that
associates with and activates Dbf2-Mob1, and ¢nally, protein
Nud1 that acts as a sca¡old for Tem1, Bub2-Bfa1, Cdc15, and
Dbf2 anchoring them on the SPB. The function of this cas-
cade is to activate, and to release from nucleolar sequestra-
tion, the phosphatase Cdc14 which, in turn, inactivates the
mitotic CDK Clb-Cdc28 through at least three di¡erent mech-
anisms (involving activation of cyclin degradation complex
Cdh1-APC, stabilization of CDK inhibitor Sic1, and activa-
tion of transcription factor Swi5 driving the expression of
Sic1). Dbf2 is genetically placed downstream of the other
MEN components, but upstream of Cdc14. Since both
Cdc14 and the nucleolar sequestering protein C¢1/Net1 are
known to be phosphorylated, it is conceivable that Dbf2 di-
rectly phosphorylates these proteins and mediates their disso-
ciation [32].
In ¢ssion yeast, the closest homologue of NDR is the pro-
tein kinase Orb6, originally identi¢ed as one of 12 orb genes
involved in cell morphogenesis [33]. Under normal growth
conditions, the S. pombe cells switch in the early G2 phase
to bipolar growth, using the new tip formed by cell division
(new end take o¡, NETO). The bipolar growth continues until
mitosis when tip elongation ceases, and the cell division com-
mences. These cell cycle transitions are accompanied by pro-
found changes in the actin cytoskeleton, involving formation
of distinct actin patches at the growing tips in interphase and
actin ring during mitosis. In the orb mutants, however, the
cells become spherical and show a complete loss of cell polar-
ity. Moreover, some of the mutants, including orb6, display
disorganized microtubules as well as a random and delocal-
ized distribution of F-actin throughout the cell cortex. Fur-
thermore, decrease of Orb6 protein also results in advanced
mitosis. On the other hand, Orb6 overexpression maintains
polarized growth, but delays mitosis by a¡ecting the mitotic
CDK kinase Cdc2, possibly through the Wee1 protein kinase
[17]. Orb6 protein is enriched at the cell tips during interphase
and at the region of developing septum during mitosis and
cytokinesis, emphasizing the role of this kinase in the main-
tenance of polarized growth and cell division. Genetic data
suggest that the correct localization of Orb6 depends on pro-
tein kinase Pak1 (also known as Shk1 or Orb2), an e¡ector of
the GTPase Cdc42. Similar to its S. cerevisiae homologue
Cbk1, Orb6 physically interacts and colocalizes with Mob2,
and the inactivation or overexpression of Mob2 results in
identical phenotypes as those observed for Orb6. Thus,
Orb6 may act downstream of Pak1, forming a part of a sig-
naling pathway coordinating cell morphogenesis with the pro-
gression through cell cycle.
The ¢ssion yeast counterpart of Dbf2 is protein kinase Sid2
that was originally isolated as a mutant defective in formation
of septum during cytokinesis [34,35]. Together with its binding
partner Mob1 (an ortholog of S. cerevisiae Mob1), it forms an
e¡ector part of S. pombe septation initiation network (SIN)
that resembles, yet is not identical to the S. cerevisiae MEN
system [36]. SIN consists of GTPase Spg1, two-component
GAP Cdc16-Byr4, SPB-anchoring proteins Sid4 and Cdc11,
protein kinases Plo1, Cdc7, as well as Sid1 and Sid2 with their
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associating factors Cdc14 (unrelated to its S. cerevisiae name-
sake) and Mob1, respectively (reviewed in [31]). The SIN
components localize at SPBs throughout mitosis, but are in-
active until formation of the metaphase spindle, which triggers
dissociation of the Cdc16-Byr4 complex, and thereby, activa-
tion of Spg1 and recruitment of Ccd7 to SPBs. During ana-
phase, Mob1-Sid2 kinase is activated in a Ccd7- and Cdc14-
Sid1-dependent manner, relocalizes to the medial ring and
£anks the septum as medial ring contracts [36,37]. Since the
Sid2 and Mob1 are the only SIN pathway components seen at
the site of the division septum, it is thought that these proteins
transmit the executive message for septum formation to the
site of cytokinesis. In addition, Mob1-Sid2 and the other SIN
pathway members could also be involved in ‘cytokinesis
checkpoint’ that acts as a safeguard preventing cells with un-
assembled division septum to enter new cell cycle [38]. This
system is not well understood yet, but it is known that it acts
through Clp1/Flp1, a S. pombe counterpart of the budding
yeast Ccd14, which can inhibit the mitotic CDK Cdc13-
Cdc2 via activation of Wee1 kinase, inhibition of Cdc25 phos-
phatase, or through promoting both events. Clp1/Flp1 is nor-
mally kept inactive by its sequestration in the nucleolus, and
after its delivery, an active SIN is needed to maintain Clp1/
Flp1 in its released state [38].
Examples from other fungal organisms further illustrate the
role of NDR family kinases in control of morphogenesis. A
mutation in cot-1 gene, which encodes the NDR homologue
Cot-1 in ¢lamentous fungi N. crassa, results in restricted col-
onial growth with formation of small and compact colonies
[39]. This growth alteration is due to a defect in hyphal tip
elongation and a concomitant increase in hyphal branching,
suggesting that Cot-1 kinase is required for one or more
events essential for hyphal outgrowth. On the other hand,
the disruption of ukc1 gene encoding NDR family member
Ukc1 in the bimorphic fungi U. maydis is manifested by
highly distorted cell morphology, inability to generate aerial
¢laments during mating, and compromised pathogenicity.
This mutant forms clusters composed of rounded cells with
hyphal extensions or elongated buds resembling chlamydo-
spore-like cells [40].
3.2. D. melanogaster
The D. melanogaster gene tricornered (trc) encodes the pro-
tein kinase TRC displaying 70% identity and 79% similarity to
the human NDR1 kinase throughout the whole protein se-
quence, indicating that these two proteins are orthologs. A
mutation in trc is associated with organismal recessive lethal-
ity, but it is still cell viable, and has been used as a gratuitous
cuticular marker in a number of genetic mosaic studies. Sig-
ni¢cantly, mutations in trc result in the splitting, clustering, or
branching of a variety of polarized structures such as epider-
mal hairs decorating the adult cuticular surface, the shafts of
bristle sense organs, the lateral extensions of the arista, and
the larval denticles ([41] and references therein). The morphol-
ogy and polarity of branched hairs, laterals, or bristles is,
however, typically normal except for the region of the branch
point. In this respect, trc di¡ers fundamentally from muta-
tions in the downstream components of frizzled tissue polarity
pathway such as inturned or actin cytoskeleton components
such as crinkled, singed, or forked which exhibit an altered
polarity of cellular projections or abnormal morphology in
all regions of the structure (reviewed in [42]. Nevertheless,
inhibition of actin polymerization in di¡erentiating cells by
cytochalasin D or latrunculin A treatment was found to phe-
nocopy the branched hairs and bristles found in trc, suggest-
ing that TRC might interact with actin cytoskeleton. Consis-
tent with this possibility, Geng et al. [41] found that a weak
trc mutant was hypersensitive to cytochalasin D treatment.
However, the drugs also result in short, fat, and occasionally
malformed hairs and bristles. Such di¡erences between phe-
notypes induced by trc mutant and the drug treatment suggest
that TRC is not simply required for actin polymerization, but
it seems more likely that TRC interacts with the actin cyto-
skeleton in a more subtle way. There are at least three possible
mechanisms for the action of TRC. It might form a part of
molecular machinery monitoring and coordinating the growth
of actin ¢laments and bundles during the outgrowth of cellu-
lar projections, the so called ‘morphogenetic checkpoint’ [43].
Alternatively, TRC protein could function in the assembly of
the cellular components that initiate and organize the out-
growth of cellular extensions. Defects in proper assembly of
such initiation centers, as well as formation of multiple or too
large initiation centers, might result in the splitting of the
extensions at later stages of elongation. Finally, TRC could
also function to mechanically strengthen the cellular projec-
tions to ensure their integrity, e.g. by increasing the degree of
cross-linking of membrane cytoskeleton.
A close NDR homologue, LATS/WARTS, was ¢rst identi-
¢ed in mosaic £y screens for tumor suppressors and negative
regulators of cell proliferation [44]. Somatic cells from lats-
negative £ies undergo extensive proliferation and form large
tumors in many tissues in mosaic adults. Moreover, homozy-
gous mutants for various lats alleles display a range of devel-
opmental defects including embryonic lethality. The lats mu-
tant clones induced at several developmental stages form
dramatically overproliferated tissues in adults. Cells in these
clones are capable of di¡erentiation on the £y body and pro-
duce bristles and hairs, but the morphology of these exten-
sions and the cell shape are altered compared to wild-type
cells [45].
3.3. C. elegans
The C. elegans gene sax-1 encodes protein kinase with 66%
identity and 74% similarity to human NDR1. Sax-1 mutants
exhibit defects in neuronal cell shape and polarity. The cells
have expanded to irregular cell bodies and initiate ectopic
neurites in several classes of sensory neurons, suggesting
that SAX-1 functions to restrict cell and neurite growth [46].
The ectopic neurites resemble the e¡ect of decreased sensory
activity in nematodes with mutations in the cGMP-gated sen-
sory transduction channel TAX-4. However, the neurons in
the sax-1/tax-4 double mutant display signi¢cantly more neu-
rites than a null mutant in either gene, indicating that these
genes function in two di¡erent pathways to suppress neurite
initiation. Similarly, mutation in unc-43 gene encoding the
C. elegans CaM-dependent kinase II (CaMKII), which has
been implicated in the regulation of neuronal morphology in
response to neural activity, leads to far more severe phenotype
in double mutants with sax-1 (but not with tax-4). None
the less, the elevated activity of UNC-43 in part suppresses
the sax-1 mutant, suggesting that UNC-43 can partially com-
pensate for the decreased SAX-1 kinase activity. Thus, the
activity-dependent pathway for neurite initiation is modulated
by UNC-43 CaMKII kinase, and functions in parallel with
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SAX-1 kinase. Of note, mutations in the GTPase RhoA pro-
duce a similar phenotype in sensory neurons as the sax-1
mutants, although the defects are less marked than those in
sax-1 worms. Most signi¢cantly, the sax-1/rhoA double mu-
tant strain has defects that are no more severe than the sax-1
single mutant, suggesting that SAX-1 and RhoA a¡ect a sim-
ilar process. In agreement with this idea, overexpression of
sax-1 partly suppresses the rhoA defects and vice versa, point-
ing to the fact that SAX-1 and RhoA may be components of
the same morphogenetic pathway or two pathways with
shared functions.
3.4. Mammals
The best studied member of NDR kinase family in mam-
mals is the protein kinase LATS1. It has been shown to local-
ize to the centrosomes in interphase, to translocate to the
mitotic spindle in metaphase and anaphase, and then to the
midbody in telophase [47]. Furthermore, it is phosphorylated
in a cell cycle-dependent manner, and interacts directly with
CDK1 in early mitosis. LATS1-associated CDK1 has no mi-
totic cyclin partner and no kinase activity, indicating that
LATS1 is a novel negative regulator of CDK1 [48]. Trans-
duction of many human tumor cell lines with LATS1 by an
adenovirus-mediated gene transfer brings about a marked in-
hibition of cell proliferation. Moreover, ectopic expression of
LATS1 speci¢cally downregulates the cyclin A and cyclin B
protein levels, and dramatically reduces CDK1 activity, lead-
ing to growth arrest in the G2/M phase. It also can induce the
level of BAX protein, thereby promoting apoptosis [49,50].
Abolition of LATS1 function in LATS13=3 mice leads to
impaired mammary gland development, infertility, growth re-
tardation, and most signi¢cantly, to the development of soft
tissue sarcomas and ovarian stromal cell tumors [51]. Taken
together, these observations suggest that LATS1 is a tumor
suppressor that suppresses tumorigenesis by negatively regu-
lating cell proliferation and modulating cell survival.
Less is currently known about the in vivo function of
NDR1 and NDR2 protein kinases. However, a number of
observations suggest that mammalian NDR may perform sim-
ilar functions as its relatives in other species. For instance,
NDR interacts with hMob1 which is the human homologue
of Mob1 and Mob2 from S. pombe and S. cerevisiae (S.J.
Bichsel et al., manuscript in preparation). This indicates that
the regulation of NDR may be analogous to the members of
NDR family in yeast. Moreover, activity of NDR appears to
be tightly cell cycle regulated also in mammalian cells (our
unpublished observations). In fact, the current data indicate
that NDR can be involved in control of cell proliferation and
tumor development. First, the NDR-activating protein S100B
is overexpressed in D80% of metastatic melanomas, and se-
rum levels of S100B are used as a prognostic marker for
tumors with poor prognosis [52]. Signi¢cantly, NDR is hyper-
activated in some S100B-positive melanoma cell lines, and
inhibitor studies suggest that S100B is the direct cause for
this elevated NDR activity [4]. Second, NDR1 mRNA level
was found to be consistently upregulated in the ductal carci-
noma in situ (DCIS) that marks high risk of invasive breast
cancer [53]. Third, both NDR1 gene location at the chromo-
some locus 6p21 and the NDR2 gene from 12p11 belong to
regions that were described as cancer amplicons ([54] and
references therein). These data suggest that NDR, along
with its partners S100B or hMob1, may form a part of novel
calcium-dependent signaling pathway that controls cell prolif-
eration, and its deregulation is involved in pathogenesis of
some malignant disorders.
4. Future perspectives
Elucidation of the NDR signaling pathway in higher organ-
isms is expected to provide further insights into the control of
cell division and morphogenesis. The example of tumor sup-
pressor LATS1 clearly illustrates the importance of NDR
family kinases in growth control in metazoans. The novel
methods of systematic identi¢cation of protein complexes by
means of high-throughput mass spectrometric protein com-
plex identi¢cation (HMS-PCI) and of identi¢cation of sup-
pressors of epistatic mutations by the synthetic genetic array
mapping (SGAM) have recently greatly illuminated the func-
tion of the Cbk1 pathway in budding yeast. For instance, this
signaling pathway was suggested to participate, through the
genetic and/or physical interactions of Cbk1 with proteins
such as SEC28, VMA6, BST1, GOS1 or SSD1, also in the
control of vesicular transport or RNA stability [55,56]. Thus,
it seems likely that, in addition to their role in diverse aspects
of cell division and morphogenesis, NDR family protein ki-
nases are involved in more cellular processes than previously
assumed. Future research will be certainly focused on inves-
tigations of such novel functions of these kinases. Finally,
although enormous progress has been achieved in character-
ization of function and components of the NDR kinase family
signaling, the speci¢c protein substrates targeted by these ki-
nases still remain to be identi¢ed.
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